SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-104228
Filing Date
2017-03-30
Accepted
2017-03-30 16:50:56
Documents
72
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d318309d10k.htm 10-K 836408
2 EX-10.21 d318309dex1021.htm EX-10.21 10007
3 EX-10.25 d318309dex1025.htm EX-10.25 35721
4 EX-23.1 d318309dex231.htm EX-23.1 1600
5 EX-31.1 d318309dex311.htm EX-31.1 9314
6 EX-31.2 d318309dex312.htm EX-31.2 9209
7 EX-32.1 d318309dex321.htm EX-32.1 6023
14 GRAPHIC g318309g48f88.jpg GRAPHIC 95022
15 GRAPHIC g318309g54w48.jpg GRAPHIC 105559
16 GRAPHIC g318309g62k37.jpg GRAPHIC 69688
17 GRAPHIC g318309g64s46.jpg GRAPHIC 69815
18 GRAPHIC g318309g97r19.jpg GRAPHIC 79920
  Complete submission text file 0001193125-17-104228.txt   4472510

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aldx-20161231.xml EX-101.INS 526226
9 XBRL TAXONOMY EXTENSION SCHEMA aldx-20161231.xsd EX-101.SCH 43351
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20161231_cal.xml EX-101.CAL 55278
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20161231_def.xml EX-101.DEF 154942
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20161231_lab.xml EX-101.LAB 384182
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20161231_pre.xml EX-101.PRE 281697
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36332 | Film No.: 17726435
SIC: 2834 Pharmaceutical Preparations